Trials / Completed
CompletedNCT05703477
The Dynamic Fluctuation of Donor Microbiota Affects the Prognosis of Fecal Microbiota Transplantation for C. Difficile Infection
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Fecal microbiota transplantation (FMT) achieves the purpose of treating intestinal and extra-intestinal diseases by transplanting the functional microbes in the feces of healthy people into the patient's intestine through the upper or lower alimentary tract routes to rebuild the patient's intestinal microbiota. Recently, FMT has been widely used in the treatment of various gastrointestinal diseases, including but not limit in CDI. In this study, we focused on the demonstration of FMT action mechanism in CDI treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Fecal microbiota transplantation | Fecal microbiota transplantation (FMT) achieves the purpose of treating intestinal and extra-intestinal diseases by transplanting the functional microbes in the feces of healthy people into the patient's intestine through the upper or lower alimentary tract routes to rebuild the patient's intestinal microbiota. |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2022-08-30
- Completion
- 2022-08-30
- First posted
- 2023-01-30
- Last updated
- 2024-01-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05703477. Inclusion in this directory is not an endorsement.